Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

3 High-Growth Tech Stocks Set to Soar

By Chris Lau, InvestorPlace Contributor

Investors sold high-growth tech stocks along with the rest of the weak companies that performed poorly last year.

7 Stocks to Buy for the $100,000 Portfolio

By Chris Lau, InvestorPlace Contributor

Companies that are resilient to a recession thrive by selling goods with strong demand and are stocks to buy for the $100,000 portfolio.

7 Stocks With a Forward P/E of 25 to Run Away From

By Chris Lau, InvestorPlace Contributor

Expensive stocks with all the warning signs of having too high a risk of missing expectations are the stocks to avoid.

7 Fintech and Tech Zombies to Sell Before 2023

By Chris Lau, InvestorPlace Contributor

Investors have seven fintech stocks to consider selling now before credit conditions worsen in the year ahead.

7 Top Stock Ideas for 2023

By Chris Lau, InvestorPlace Contributor

Top stocks are not speculative, as business growth fuels profit expansion.

Load More